G蛋白偶联受体在宿主抗结核分枝杆菌感染中的功能及作用机制

doi:10.19982/j.issn.1000-6621.20240118

摘要/Abstract

摘要：

G蛋白偶联受体(GPCRs)在维持人体正常生理功能和细胞内稳态过程中发挥关键作用。GPCRs及其下游信号通路的表达失调是疾病发生发展的重要标志。近年来,结核病的防治面临着更加严峻的挑战,亟需研发安全、价廉、敏感的新型抗结核药物。其中,基于宿主导向治疗策略的新型抗菌药物受到广泛关注,而GPCRs作为宿主发挥免疫表达调控作用的受体之一,可作为宿主导向的抗结核潜在治疗靶标,然而GPCRs作为重要的药物研究靶点在结核病领域的研究尚显不足。笔者总结了近年来发现的GPCRs在宿主细胞应答结核分枝杆菌感染中所发挥的功能,系统综述了趋化因子受体类GPCRs、孤儿GPCRs及其他GPCRs在调控宿主细胞信号转导中发挥的关键作用和分子机制,为基于GPCRs的抗结核药物研发提供依据。

关键词: 受体, G-蛋白偶联, 巨噬细胞, 分枝杆菌,结核, 感染

Abstract:

G protein-coupled receptors (GPCRs) play a critical role in maintaining normal physiological functions and intracellular homeostasis in the human body. Dysregulation of GPCRs and their downstream signaling pathways are significant markers in the development and progression of various diseases. In recent years, the prevention and treatment of tuberculosis (TB) have faced increasingly severe challenges, highlighting the urgent need for the development of new anti-TB drugs that are safe, affordable, and sensitive. Among these, novel antimicrobial drugs based on host-directed therapeutic strategies have garnered widespread attention. GPCRs, as receptors that regulate host immune expression, can serve as potential therapeutic targets for host-directed anti-TB treatment. However, researches on GPCRs as important drug targets in the field of TB are still insufficient. The author summarizes the recently discovered functions of GPCRs in host cell responses to Mycobacterium tuberculosis infection. It systematically reviews the key roles and molecular mechanisms of chemokine receptor-like GPCRs, orphan GPCRs, and other GPCRs in regulating host cell signal transduction, providing a basis for the development of GPCR-based anti-TB drugs.

Key words: Receptors, G-protein-coupled, Macrophages, Mycobacterium tuberculosis, Infection

中图分类号:

R373.5
R392

刘浩瀚, 马子淳, 逄宇, 李姗姗. G蛋白偶联受体在宿主抗结核分枝杆菌感染中的功能及作用机制[J]. 中国防痨杂志, 2024, 46(7): 839-844. doi: 10.19982/j.issn.1000-6621.20240118

Liu Haohan, Ma Zichun, Pang Yu, Li Shanshan. The function and mechanism of G protein-coupled receptors in host against Mycobacterium tuberculosis infection[J]. Chinese Journal of Antituberculosis, 2024, 46(7): 839-844. doi: 10.19982/j.issn.1000-6621.20240118

参考文献 42

[1]	Weis WI, Kobilka BK. The Molecular Basis of G Protein-Coupled Receptor Activation. Annu Rev Biochem, 2018, 87: 897-919. doi:10.1146/annurev-biochem-060614-033910. pmid: 29925258
[2]	Elkington PT, Emerson JE, Lopez-Pascua LD, et al. Mycobacterium tuberculosis up-regulates matrix metalloproteinase-1 secretion from human airway epithelial cells via a p 38 MAPK switch. J Immunol, 2005, 175(8):5333-5340. doi:10.4049/jimmunol.175.8.5333. pmid: 16210639
[3]	Dixon RA, Kobilka BK, Strader DJ, et al. Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin. Nature, 1986, 321(6065):75-79. doi:10.1038/321075a0.
[4]	Sojka AC, Brennan KM, Maizels ET, et al. The Science Behind G Protein-Coupled Receptors (GPCRs) and Their Accurate Visual Representation in Scientific Research. J Biocommun, 2017, 41(1):e6. doi:10.5210/jbc.v41i1.7309. pmid: 36405408
[5]	Alexander SPH, Christopoulos A, Davenport AP, et al. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors. Br J Pharmacol, 2019, 176 Suppl 1(Suppl 1): S21-S141. doi:10.1111/bph.14748.
[6]	Crilly SE, Puthenveedu MA. Compartmentalized GPCR Signaling from Intracellular Membranes. J Membr Biol, 2021, 254(3):259-271. doi:10.1007/s00232-020-00158-7.
[7]	Miyano K, Sudo Y, Yokoyama A, et al. History of the G protein-coupled receptor (GPCR) assays from traditional to a state-of-the-art biosensor assay. J Pharmacol Sci, 2014, 126(4):302-309. doi:10.1254/jphs.14R13CP. pmid: 25421710
[8]	Ahmad F, Rani A, Alam A, et al. Macrophage: A Cell With Many Faces and Functions in Tuberculosis. Front Immunol, 2022,13:747799. doi:10.3389/fimmu.2022.747799.
[9]	王晓蕾. 结核病感染免疫相关因子IL-10的表达调控及MCP-1基因多态性的研究. 济南:山东大学, 2018.
[10]	Peters W, Scott HM, Chambers HF, et al. Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis. Proc Natl Acad Sci U S A, 2001, 98(14):7958-7963. doi:10.1073/pnas.131207398.
[11]	Møller AS, Øvstebø R, Westvik AB, et al. Effects of bacterial cell wall components (PAMPs) on the expression of monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and the chemokine receptor CCR2 by purified human blood monocytes. J Endotoxin Res, 2003, 9(6):349-360. doi:10.1179/096805103225002791.
[12]	Arias MA, Pantoja AE, Jaramillo G, et al. Chemokine receptor expression and modulation by Mycobacterium tuberculosis antigens on mononuclear cells from human lymphoid tissues. Immunology, 2006, 118(2):171-184. doi:10.1111/j.1365-2567.2006.02352.x.
[13]	Joosten SA, van Meijgaarden KE, Savage ND, et al. Identification of a human CD8⁺ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4. Proc Natl Acad Sci U S A, 2007, 104(19):8029-8034. doi:10.1073/pnas.0702257104.
[14]	Wahl SM, Greenwell-Wild T, Peng G, et al. Co-infection with opportunistic pathogens promotes human immunodeficiency virus type 1 infection in macrophages. J Infect Dis, 1999,179 Suppl 3:S457-S460. doi:10.1086/314814.
[15]	Novita BD, Tjahjono Y, Wijaya S, et al. Characterization of chemokine and cytokine expression pattern in tuberculous lymphadenitis patient. Front Immunol, 2022, 13: 983269. doi:10.3389/fimmu.2022.983269.
[16]	Badewa AP, Quinton LJ, Shellito JE, et al. Chemokine receptor 5 and its ligands in the immune response to murine tuberculosis. Tuberculosis (Edinb), 2005, 85(3):185-195. doi:10.1016/j.tube.2004.10.003.
[17]	Xiao T, Cai Y, Chen B. HIV-1 Entry and Membrane Fusion Inhibitors. Viruses, 2021, 13(5): 735. doi:10.3390/v13050735.
[18]	Wahl SM, Greenwell-Wild T, Peng G, et al. Mycobacterium avium complex augments macrophage HIV-1 production and increases CCR5 expression. Proc Natl Acad Sci U S A, 1998, 95(21):12574-12579. doi:10.1073/pnas.95.21.12574.
[19]	Boro M, Balaji KN. CXCL1 and CXCL2 Regulate NLRP3 Inflammasome Activation via G-Protein-Coupled Receptor CXCR2. J Immunol, 2017, 199(5):1660-1671. doi:10.4049/jimmunol.1700129. pmid: 28739876
[20]	Gonçalves AS, Appelberg R. The involvement of the chemokine receptor CXCR2 in neutrophil recruitment in LPS-induced inflammation and in Mycobacterium avium infection. Scand J Immunol, 2002, 55(6): 585-591. doi:10.1046/j.1365-3083.2002.01097.x.
[21]	Koper OM, Kamińska J, Sawicki K, et al. CXCL9, CXCL10, CXCL11, and their receptor (CXCR3) in neuroinflammation and neurodegeneration. Adv Clin Exp Med, 2018, 27(6):849-856. doi:10.17219/acem/68846. pmid: 29893515
[22]	Sommer F, Torraca V, Kamel SM, et al. Frontline Science: Antagonism between regular and atypical Cxcr 3 receptors regulates macrophage migration during infection and injury in zebrafish. J Leukoc Biol, 2020, 107(2):185-203. doi:10.1002/JLB.2HI0119-006R.
[23]	Sun H, Fan J, Shang X, et al. Study on the relationship between CXCR3 and its ligands and tubal tuberculosis. Life Sci, 2021,272:119047. doi:10.1016/j.lfs.2021.119047.
[24]	Juarez J, Bendall L. SDF-1 and CXCR4 in normal and malignant hematopoiesis. Histol Histopathol, 2004, 19(1):299-309. doi:10.14670/HH-19.299. pmid: 14702198
[25]	Cowley S. The biology of HIV infection. Lepr Rev, 2001, 72(2):212-220. doi:10.5935/0305-7518.20010028.
[26]	Hoshino Y, Tse DB, Rochford G, et al. Mycobacterium tuberculosis-induced CXCR4 and chemokine expression leads to preferential X4 HIV-1 replication in human macrophages. J Immunol, 2004, 172(10):6251-6258. doi:10.4049/jimmunol.172.10.6251. pmid: 15128813
[27]	Torraca V, Tulotta C, Snaar-Jagalska BE, et al. The chemokine receptor CXCR4 promotes granuloma formation by sustaining a mycobacteria-induced angiogenesis programme. Sci Rep, 2017,7:45061. doi:10.1038/srep45061.
[28]	Gopal R, Rangel-Moreno J, Slight S, et al. Interleukin-17-dependent CXCL 13 mediates mucosal vaccine-induced immunity against tuberculosis. Mucosal Immunol, 2013, 6(5):972-984. doi:10.1038/mi.2012.135. pmid: 23299616
[29]	Zhang Y, Li S, Liu Q, et al. Mycobacterium tuberculosis Heat-Shock Protein 16.3 Induces Macrophage M2 Polarization Through CCRL2/CX3CR1. Inflammation, 2020, 43(2):487-506. doi:10.1007/s10753-019-01132-9.
[30]	Hall JD, Kurtz SL, Rigel NW, et al. The impact of chemokine receptor CX3CR1 deficiency during respiratory infections with Mycobacterium tuberculosis or Francisella tularensis. Clin Exp Immunol, 2009, 156(2):278-284. doi:10.1111/j.1365-2249.2009.03882.x.
[31]	Vance J, Santos A, Sadofsky L, et al. Effect of High Glucose on Human Alveolar Macrophage Phenotype and Phagocytosis of Mycobacteria. Lung, 2019, 197(1):89-94. doi:10.1007/s00408-018-0181-z. pmid: 30474709
[32]	Bo H, Moure UAE, Yang Y, et al. Mycobacterium tuberculosis-macrophage interaction: Molecular updates. Front Cell Infect Microbiol, 2023,13:1062963. doi:10.3389/fcimb.2023.1062963.
[33]	Recio C, Lucy D, Purvis GSD, et al. Activation of the Immune-Metabolic Receptor GPR84 Enhances Inflammation and Phagocytosis in Macrophages. Front Immunol, 2018,9:1419. doi:10.3389/fimmu.2018.01419.
[34]	Peterson PK, Gekker G, Hu S, et al. Morphine stimulates phagocytosis of Mycobacterium tuberculosis by human microglial cells: involvement of a G protein-coupled opiate receptor. Adv Neuroimmunol, 1995, 5(3):299-309. doi:10.1016/0960-5428(95)00020-3. pmid: 8748073
[35]	Lee HJ, Ko HJ, Song DK, et al. Lysophosphatidylcholine Promotes Phagosome Maturation and Regulates Inflammatory Mediator Production Through the Protein Kinase A-Phosphatidylinositol 3 Kinase-p38 Mitogen-Activated Protein Kinase Signaling Pathway During Mycobacterium tuberculosis Infection in Mouse Macrophages. Front Immunol, 2018,9:920. doi:10.3389/fimmu.2018.00920.
[36]	Santos AA Jr, Rodrigues-Junior V, Zanin RF, et al. Implication of purinergic P2X7 receptor in M.tuberculosis infection and host interaction mechanisms: a mouse model study. Immunobiology, 2013, 218(8):1104-1112. doi:10.1016/j.imbio.2013.03.003. pmid: 23583008
[37]	Soares-Bezerra RJ, Pinho RT, Bisaggio Rda C, et al. The Search for New Agonists to P2X7R for Clinical Use: Tuberculosis as a Possible Target. Cell Physiol Biochem, 2015, 37(2):409-418. doi:10.1159/000430364. pmid: 26314826
[38]	Humphreys BD, Rice J, Kertesy SB, et al. Stress-activated protein kinase/JNK activation and apoptotic induction by the macrophage P2X7 nucleotide receptor. J Biol Chem, 2000, 275(35):26792-26798. doi:10.1074/jbc.M002770200. pmid: 10854431
[39]	Kusner DJ, Barton JA. ATP stimulates human macrophages to kill intracellular virulent Mycobacterium tuberculosis via calcium-dependent phagosome-lysosome fusion. J Immunol, 2001, 167(6):3308-3315. doi:10.4049/jimmunol.167.6.3308. pmid: 11544319
[40]	Coutinho-Silva R, Stahl L, Raymond MN, et al. Inhibition of chlamydial infectious activity due to P2X7R-dependent phospholipase D activation. Immunity, 2003, 19(3):403-412. doi:10.1016/s1074-7613(03)00235-8. pmid: 14499115
[41]	Amaral EP, Ribeiro SC, Lanes VR, et al. Pulmonary infection with hypervirulent Mycobacteria reveals a crucial role for the P2X7 receptor in aggressive forms of tuberculosis. PLoS Pathog, 2014, 10(7):e1004188. doi:10.1371/journal.ppat.1004188.
[42]	Di Liberto D, Locati M, Caccamo N, et al. Role of the chemokine decoy receptor D 6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection. J Exp Med, 2008, 205(9):2075-2084. doi:10.1084/jem.20070608.